Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Voyageur Pharmaceuticals Ltd VYYRF


Primary Symbol: V.VM

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > This is why formulations took so long, great strategy!
View:
Post by biggdogg on Sep 18, 2024 2:04pm

This is why formulations took so long, great strategy!

https://www.linkedin.com/feed/update/urn:li:activity:7242229253763710976/
Comment by postie1 on Sep 18, 2024 6:46pm
That explains a lot. Plus VM still has the generics to fall back on. Should be a 20 yr. patent on these formulas and another company would have to find a natural deposit. Superior product and 20 yrs. protection plus the Rain Cage stuff should make VM very interesting to the big boys. These boys certainly were not sitting idle.(I also understand the frustration that people have but from the asks ...more  
Comment by biggdogg on Sep 18, 2024 8:11pm
Something has to break loose soon. You don't bring on a high profile CSO unless there is something cooking behind the scenes  
Comment by postie1 on Sep 19, 2024 11:46am
since she knows the FDA maybe that is closer than we know. I am also wondering if that Vanadium/raincage stuff might be getting closer to advancement stage. Since VM is very closed mouth we will not hear until after the fact.
Comment by WarrantOfficer on Sep 19, 2024 8:47am
Could you copy and paste this article for those whom do not have an linkedin account please?
Comment by Mbxwatcher on Sep 19, 2024 10:44am
https://www.paidpromotionalmessages.com/companies/news/1056486/voyageur-pharmaceuticals-announces-new-line-of-barium-contrast-formulations-setting-new-standard-1056486.html
Comment by biggdogg on Sep 19, 2024 11:24am
https://www.paidpromotionalmessages.com/companies/news/1056486/voyageur-pharmaceuticals-announces-new-line-of-barium-contrast-formulations-setting-new-standard-1056486.html
Comment by biggdogg on Sep 19, 2024 11:29am
You need to go to Proactive Investor website, and watch the latest interview with Voyageur. The link is blocked by Stockhouse, as they are a competitor. Obviously Voyageur is using multiple marketing platforms, I see them on Stockhouse, Proactive Investor, and Investor News investornews.com/ paidpromotionalmessages.com
Comment by postie1 on Sep 19, 2024 11:38am
this youtube linkmight be allowed. On thelinked in close the pop up window and hit the rorple link also Voyageur Pharmaceuticals announces new line of Barium Contrast Formulations setting new standard (youtube.com)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities